Nasonal 1 Mg/Ml (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Nasonal 1 Mg/Ml, is an imidazoline derivative (nasal decongestant) presented as a 1 mg/mL nasal solution for nasal use. It relieves nasal congestion associated with the common cold, sinusitis, and allergic rhinitis in adults and children.

GNH USA supplies Nasonal 1 Mg/Ml as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and other healthcare providers worldwide.

Xylometazoline Hydrochloride works as a topical nasal decongestant to reduce swelling of the nasal mucosa in several common conditions.

- Common cold nasal congestion: reduces swelling and improves airflow. - Sinusitis‑related congestion: alleviates mucosal edema for better sinus drainage. - Allergic rhinitis: decreases nasal obstruction caused by allergic inflammation.

Nasal decongestants may cause local and systemic reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation. - Dryness of the nasal mucosa. - Sneezing or mild itching. - Headache. - Altered taste or bitter after‑taste. - Transient epistaxis (nosebleed).

Serious or Rare Side Effects: - Severe hypertension or hypertensive crisis. - Cardiac arrhythmias. - Nasal septum perforation with prolonged misuse. - Anaphylactic reaction. - Rebound congestion (rhinitis medicamentosa) after extended use. - Vision disturbances (rare).

Before using Xylometazoline Hydrochloride, consider the following safety measures.

- Pregnancy: safety not established; consult a healthcare professional. - Children under 2 years: avoid unless specifically directed by a clinician. - Cardiovascular disease: use with caution due to possible blood pressure effects. - Concomitant sympathomimetic drugs: monitor for additive cardiovascular stimulation. - Duration of use: limit to no more than three consecutive days to prevent rebound congestion. - Store at room temperature: keep in the original container, protect from moisture and heat.

Xylometazoline Hydrochloride can interact with other medications that affect the cardiovascular or sympathetic systems.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Other nasal decongestants: additive vasoconstriction may increase adverse effects. - Systemic sympathomimetics (e.g., pseudoephedrine): heightened cardiovascular stimulation.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: possible reduction in blood‑pressure‑lowering effect. - Beta‑blockers: may blunt compensatory cardiovascular responses. - Tricyclic antidepressants: potential additive sympathomimetic activity.